Last reviewed · How we verify
Prevention of Liver Transplant Rejection
Approved treatments
- Sandimmune · Novartis
- Prograf · Astellas Pharma
Prograf works by inhibiting the activation of T-lymphocytes, a type of immune cell. - Mycophenolate · Sanofi
- Sandimmune · Novartis AG (originally Sandoz)
Calcineurin inhibitor that suppresses T-cell activation by blocking IL-2 transcription, preventing organ transplant rejection. - ciclosporine · Hospices Civils de Lyon
- Cellcept · Roche Palo
Cellcept works by inhibiting the enzyme inosine-5'-monophosphate dehydrogenase 2, which is necessary for the production of guanosine nucleotides. - Mycophenolate · Novartis
- Neoral · Novartis Pharmaceuticals
- Cyclosporin · Karolinska University Hospital
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Prevention of Liver Transplant Rejection patent landscape — cliff calendar, originator estates, attackable patents
- Prevention of Liver Transplant Rejection treatment landscape brief
- Prevention of Liver Transplant Rejection treatment updates RSS
Frequently asked questions about Prevention of Liver Transplant Rejection
What drugs treat Prevention of Liver Transplant Rejection?
Tracked treatments include Sandimmune, Prograf, Mycophenolate, ciclosporine, Cellcept, Neoral, Cyclosporin.
What is the treatment for Prevention of Liver Transplant Rejection?
Standard treatment for Prevention of Liver Transplant Rejection includes Sandimmune, Prograf, Mycophenolate, ciclosporine, Cellcept. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Prevention of Liver Transplant Rejection patent cliff · Prevention of Liver Transplant Rejection CI report
- Treatment: Sandimmune · Novartis
- Treatment: Prograf · Astellas Pharma
- Treatment: Mycophenolate · Sanofi
- Treatment: Sandimmune · Novartis AG (originally Sandoz)
- Treatment: ciclosporine · Hospices Civils de Lyon
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing